Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhibitors within the nephron.

F L Coe1, Y Nakagawa, J H Parks

  • 1Nephrology Section, University of Chicago, IL 60637.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.

Kidney international·2007
Same author

Urine calcium excretion predicts bone loss in idiopathic hypercalciuria.

Kidney international·2006
Same author

Renal crystal deposits and histopathology in patients with cystine stones.

Kidney international·2006
Same author

Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

Kidney international·2006
Same author

Urinary cystine excretion and capacity in patients with cystinuria.

Kidney international·2006
Same author

Patient adherence to long-term medical treatment of kidney stones.

The Journal of urology·2001
Same journal

Progressive Kidney Dysfunction and Ocular Clues: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Influence of Lactate Dehydrogenase on the Measurement of Blood Bicarbonate.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Urinary CXCL9 and CXCL10, Interstitial Inflammation and Disease Activity Over Time in Acute Interstitial Nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Kidney Transplantation Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Multiple Myeloma.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Palliative Dialysis: Putting the Person First in Dialysis Care.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles

Kidney inhibitors like nephrocalcin (NC) and Tamm-Horsfall glycoprotein (THP) prevent kidney stones. Abnormal NC in stone formers impairs this protective function, leading to calcium oxalate monohydrate (COM) crystal formation.

Area of Science:

  • Nephrology
  • Biochemistry
  • Crystallography

Background:

  • Kidney-derived inhibitors are crucial for preventing pathological calcifications and crystallizations.
  • Nephrocalcin (NC) and Tamm-Horsfall glycoprotein (THP) are key inhibitors produced in specific nephron segments.
  • Calcium oxalate monohydrate (COM) is the primary crystalline component of human renal stones.

Purpose of the Study:

  • To elucidate the roles of NC and THP in inhibiting crystal formation and aggregation.
  • To investigate the molecular basis of impaired inhibition in patients forming COM stones.

Main Methods:

  • Characterization of NC and THP functions in crystal growth and aggregation assays.
  • Analysis of NC molecular structure, specifically gamma-carboxyglutamic acid content, in stone-forming patients.

Related Experiment Videos

Main Results:

  • NC inhibits both growth and aggregation of COM crystals.
  • THP specifically inhibits COM aggregation.
  • Abnormal NC molecules lacking gamma-carboxyglutamic acid were identified in patients with COM stones.
  • These abnormal NC variants exhibit reduced inhibitory capacity against COM crystallization.

Conclusions:

  • NC and THP play distinct but vital roles in preventing renal stone formation.
  • Defective NC, particularly the absence of gamma-carboxyglutamic acid, is a key factor in the pathogenesis of COM nephrolithiasis.
  • Understanding these inhibitory mechanisms offers potential therapeutic targets for kidney stone disease.